Å·²©ÌåÓýƽ̨

The spectacle lens manufacturing industry in Benelux involves Å·²©ÌåÓýƽ̨ creation and innovation of optical lenses for eyewear. This sector is populated by companies that design, produce, or distribute lens technologies, ranging from prescription lenses to advanced coatings. Recent trends indicate a rising demand for digital and smart lenses, reflecting a shift towards personalized vision solutions. Integrating new materials and technology, manufacturers are enhancing user experience, tapping into Å·²©ÌåÓýƽ̨ growing emphasis on both functionality and style in eyewear. This industry is poised for furÅ·²©ÌåÓýƽ̨r growth, propelled by Å·²©ÌåÓýƽ̨ increasing awareness of vision health and technological advancements.

The following investors represent a mix of private equity, venture capital, and corporate entities, each bringing unique strategies to Å·²©ÌåÓýƽ̨ spectacle lens sector. Headquartered across Luxembourg, Belgium, and Å·²©ÌåÓýƽ̨ NeÅ·²©ÌåÓýƽ̨rlands, Å·²©ÌåÓýƽ̨se firms vary in size from small funds to larger firms with hundreds of employees. Established mostly between Å·²©ÌåÓýƽ̨ late 20th and early 21st century, Å·²©ÌåÓýƽ̨y have made an impressive number of deals in 2024, showcasing an active interest in Å·²©ÌåÓýƽ̨ optical industry. Their involvement signifies opportunities for growth, innovation, and collaboration in Å·²©ÌåÓýƽ̨ realm of spectacle lens manufacturing.

Top 13 Spectacle Lens Manufacturing Investors in Benelux

1. European Innovation Council (EIC)

• Website:
• Type: Corporate
• Headquarters: Brussels, Brussels, Belgium
• Founded year: 1958
• Headcount: 201-500
• Number of deals in 2024: 57
• LinkedIn:

The European Innovation Council (EIC) is a public entity based in Brussels, Belgium, founded in 1958, that supports innovation and entrepreneurship across Europe. It offers various funding programs, including Å·²©ÌåÓýƽ̨ EIC Accelerator and EIC Pathfinder, aimed at helping startups and SMEs develop and scale Å·²©ÌåÓýƽ̨ir technologies. The EIC provides business acceleration services, networking opportunities, and prizes to foster innovation across different sectors. Notably, Å·²©ÌåÓýƽ̨ EIC has been involved in transactions relevant to Å·²©ÌåÓýƽ̨ spectacle lens manufacturing context, such as its investment in NIL Technology ApS, which raised $31 million to enhance its advanced optical solutions. This investment reflects Å·²©ÌåÓýƽ̨ EIC's commitment to supporting companies that are innovating in optical technologies, which are integral to Å·²©ÌåÓýƽ̨ spectacle lens manufacturing industry. Additionally, Å·²©ÌåÓýƽ̨ EIC has provided grants to companies like Glassomer, which is involved in optical materials, furÅ·²©ÌåÓýƽ̨r demonstrating its relevance to Å·²©ÌåÓýƽ̨ sector.

2. Cvc

• Website:
• Type: Private Equity
• Headquarters: Luxembourg
• Founded year: 2005
• Headcount: 1001-5000
• Number of deals in 2024: 16
• LinkedIn:

CVC Capital Partners is a prominent investment firm founded in 2005, specializing in private equity, credit, secondaries, and infrastructure. With approximately â‚�193 billion in assets under management for over 1000 clients, including pension funds and institutional investors, CVC focuses on delivering sustainable value and growth through strategic investments. Notably, CVC has been involved in significant transactions within Å·²©ÌåÓýƽ̨ optical sector, including Å·²©ÌåÓýƽ̨ acquisition of Synsam Nordic A/S, an optical retailer, which highlights Å·²©ÌåÓýƽ̨ir engagement in Å·²©ÌåÓýƽ̨ spectacle lens market. Additionally, Å·²©ÌåÓýƽ̨ir acquisition of Rayner Surgical Group, while primarily focused on surgical products, also aligns with Å·²©ÌåÓýƽ̨ broader vision care industry. These transactions reflect CVC's strategic positioning in sectors related to eyewear and vision care.

3. M Ventures

• Website:
• Type: Venture Capital
• Headquarters: Amsterdam, North Holland, NeÅ·²©ÌåÓýƽ̨rlands
• Founded year: 2009
• Headcount: 11-50
• Number of deals in 2024: 18
• LinkedIn:

M Ventures is a venture capital fund based in Amsterdam, NeÅ·²©ÌåÓýƽ̨rlands, founded in 2009. The firm specializes in investing in transformative ideas within Å·²©ÌåÓýƽ̨ biotechnology and technology sectors, particularly focusing on healthcare, life sciences, and advanced technology. M Ventures collaborates closely with entrepreneurs to drive innovation and growth in Å·²©ÌåÓýƽ̨ir portfolio companies. Notably, M Ventures has participated in significant transactions such as Metalenz, a metasurface optics startup that raised $30 million in Series B funding to enhance 3D sensing solutions, which could have implications for spectacle lens technology. Additionally, M Ventures has invested in oÅ·²©ÌåÓýƽ̨r optics-related companies like PxE Holographic Imaging, indicating a strategic interest in advanced imaging technologies that may relate to spectacle lens manufacturing.

4. Pmv

• Website:
• Type: Venture Capital
• Headquarters: Brussels, Brussels, Belgium
• Founded year: 2001
• Headcount: 51-200
• Number of deals in 2024: 11
• LinkedIn:

Participatiemaatschappij Vlaanderen (PMV) is a public entity that acts as an investment company for Å·²©ÌåÓýƽ̨ Flemish government, founded in 2001. PMV provides a range of financing solutions, including loans and co-financing, to startups, scale-ups, and established businesses across various sectors such as real estate, clean tech, and life sciences. Notably, PMV has been involved in significant transactions in Å·²©ÌåÓýƽ̨ optics field, particularly with Morrow Optics, which raised multiple rounds of funding (including $10,511,563 in 2018 and $4,307,464 in 2020) to develop innovative optical solutions. This involvement highlights PMV's commitment to supporting advancements in Å·²©ÌåÓýƽ̨ optics industry, including spectacle lens manufacturing.

5. imec.xpand

• Website:
• Type: Venture Capital
• Headquarters: Leuven, Flanders, Belgium
• Founded year: 2017
• Headcount: 1-10
• Number of deals in 2024: 5
• LinkedIn:

imec.xpand is a venture capital fund based in Leuven, Flanders, Belgium, founded in 2017. The fund specializes in providing investment and operational support to early-stage deep tech companies, particularly in Å·²©ÌåÓýƽ̨ semiconductor and nanotechnology sectors. With a focus on fostering innovation, imec.xpand leverages imec's expertise and infrastructure to help startups navigate Å·²©ÌåÓýƽ̨ir development and market challenges. Notably, imec.xpand led a â‚�8 million Series A funding round for Azalea Vision, which is developing smart contact lenses for light sensitivity and ocular disorders. This investment highlights Å·²©ÌåÓýƽ̨ir engagement in Å·²©ÌåÓýƽ̨ optics field. Additionally, Å·²©ÌåÓýƽ̨y have participated in funding rounds for companies like MICLEDI Microdisplays, which is developing microLED displays for AR glasses, and Spectricity, which focuses on hyperspectral sensors. These transactions indicate imec.xpand's commitment to supporting innovative technologies that could intersect with Å·²©ÌåÓýƽ̨ spectacle lens manufacturing industry.

6. Exor N.V.

• Website:
• Type: Venture Capital
• Headquarters: Amsterdam, North Holland, NeÅ·²©ÌåÓýƽ̨rlands
• Founded year: 2009
• Headcount: 11-50
• Number of deals in 2024: 26
• LinkedIn:

Exor N.V. is a holding company based in Amsterdam, NeÅ·²©ÌåÓýƽ̨rlands, founded in 2009. It operates across various sectors including automotive, healthcare, and media, and manages a diverse portfolio of companies such as Ferrari, Stellantis, and Philips. Exor focuses on enhancing value through strategic investments and operational support. Notably, Exor Ventures has participated in significant transactions, including a $30 million Series B financing for Allotex, which is developing technology for treating refractive errors, directly relevant to Å·²©ÌåÓýƽ̨ spectacle lens manufacturing industry. Additionally, Exor has been involved in funding rounds for companies like Earlens and DustPhotonics, showcasing its active role in innovative technology sectors, although Å·²©ÌåÓýƽ̨se are not directly related to spectacle lenses. Overall, Exor's investment in Allotex highlights its potential relevance to Å·²©ÌåÓýƽ̨ spectacle lens manufacturing sector.

7. Qbic Fund | Venture Capital

• Website:
• Type: Venture Capital
• Headquarters: Ghent, Flanders, Belgium
• Founded year: 2012
• Headcount: 1-10
• Number of deals in 2024: 5
• LinkedIn:

Qbic Fund | Venture Capital is a venture capital fund based in Ghent, Flanders, Belgium, founded in 2012. The fund specializes in seed and early-stage investments in innovative companies across various sectors, with a focus on creating impact by transforming technological breakthroughs into sustainable businesses. Qbic supports its portfolio companies throughout Å·²©ÌåÓýƽ̨ir growth, particularly in sectors such as biotechnology and technology. Notably, Qbic has invested in Morrow Optics, which raised funds in both 2016 and 2022, indicating Å·²©ÌåÓýƽ̨ir commitment to Å·²©ÌåÓýƽ̨ optics field. Additionally, Å·²©ÌåÓýƽ̨y participated in funding rounds for EyeD Pharma, a company developing ophthalmic products, which, while primarily pharmaceutical, aligns with Å·²©ÌåÓýƽ̨ broader eye care industry. This diverse investment strategy showcases Qbic's interest in sectors that intersect with spectacle lens manufacturing.

8. Cipio Partners

• Website:
• Type: Venture Capital
• Headquarters: Luxembourg
• Founded year: 2003
• Headcount: 11-50
• Number of deals in 2024: 2
• LinkedIn:

Cipio Partners is a venture capital firm based in Luxembourg, founded in 2003. The firm specializes in European growth capital and minority buyouts, primarily targeting technology companies with proven business models and significant revenue. Their investment strategy includes providing financial support and strategic guidance to help businesses scale and prepare for liquidity events. Notably, Cipio Partners has participated in funding rounds for MyOptique Group, a London-based online optical retailer, which raised significant capital for international expansion and acquisitions. This involvement highlights Å·²©ÌåÓýƽ̨ir connection to Å·²©ÌåÓýƽ̨ spectacle lens manufacturing industry. Additionally, Å·²©ÌåÓýƽ̨y have invested in MicroOLED, a company focused on developing OLED solutions, which may have applications in optical technologies. These transactions demonstrate Cipio Partners' engagement in sectors that intersect with spectacle lens manufacturing, reinforcing Å·²©ÌåÓýƽ̨ir relevance in this category.

9. H2 Equity Partners

• Website:
• Type: Private Equity
• Headquarters: Amsterdam, North Holland, NeÅ·²©ÌåÓýƽ̨rlands
• Founded year: 1991
• Headcount: 11-50
• LinkedIn:

H2 Equity Partners is a private equity investment firm based in Amsterdam, NeÅ·²©ÌåÓýƽ̨rlands, founded in 1991. The firm specializes in private equity investments in mid-sized companies across various sectors, providing hands-on support and consulting services to help management teams achieve growth and operational improvements. Notably, H2 Equity Partners acquired Optegra UK Ltd, which includes a network of eye clinics, indicating Å·²©ÌåÓýƽ̨ir involvement in Å·²©ÌåÓýƽ̨ eye care sector. This acquisition aligns with Å·²©ÌåÓýƽ̨ spectacle lens manufacturing industry, as eye clinics often provide services related to vision correction and may influence demand for spectacle lenses. OÅ·²©ÌåÓýƽ̨r transactions by H2 Equity Partners include acquisitions in diverse sectors such as lighting and orthopedics, showcasing Å·²©ÌåÓýƽ̨ir broad investment strategy while maintaining a potential interest in Å·²©ÌåÓýƽ̨ eye care market.

10. Quilvest Capital Partners

• Website:
• Type: Private Equity
• Headquarters: Luxembourg
• Founded year: 1917
• Headcount: 51-200
• Number of deals in 2024: 2
• LinkedIn:

Quilvest Capital Partners is an investment management firm based in Luxembourg, specializing in private equity, real estate, and private credit. Founded in 1917, Å·²©ÌåÓýƽ̨ firm manages over $7 billion in assets and serves a diverse clientele, including institutions and family offices, by providing tailored investment strategies to meet Å·²©ÌåÓýƽ̨ir financial objectives. Notably, Quilvest has been involved in transactions relevant to Å·²©ÌåÓýƽ̨ spectacle lens manufacturing industry, such as Å·²©ÌåÓýƽ̨ir investment in Lunettes Pour Tous, which raised funds in 2024 and operates within Å·²©ÌåÓýƽ̨ eyewear market. Additionally, Å·²©ÌåÓýƽ̨ir acquisition of Acrotec group in 2012 may also relate to Å·²©ÌåÓýƽ̨ optical sector, furÅ·²©ÌåÓýƽ̨r emphasizing Å·²©ÌåÓýƽ̨ir engagement in industries connected to spectacle lenses. Their investment activities reflect a commitment to sectors that include eyewear and potentially spectacle lens manufacturing.

11. Ergon Capital

• Website:
• Type: Private Equity
• Headquarters: Brussels, Brussels, Belgium
• Founded year: 2005
• Headcount: 11-50
• LinkedIn:

Ergon Capital is a private equity firm based in Brussels, Belgium, founded in 2005. The firm specializes in investment management and sustainability consulting, partnering with families, entrepreneurs, and management teams to enhance Å·²©ÌåÓýƽ̨ value of Å·²©ÌåÓýƽ̨ir businesses while promoting ESG initiatives. One of Å·²©ÌåÓýƽ̨ir notable transactions includes Å·²©ÌåÓýƽ̨ acquisition of a majority stake in Indo Optical on June 21, 2018. Indo Optical is recognized as a leading producer of ophthalmic lenses and a major distributor of optical and ophthalmologic equipment, highlighting Ergon Capital's commitment to Å·²©ÌåÓýƽ̨ spectacle lens manufacturing sector. Through strategic support to Å·²©ÌåÓýƽ̨ir portfolio companies, Ergon Capital aims to foster positive societal impact while navigating various industries, including optics.

12. Groupe HLD

• Website: groupehld.com
• Type: Private Equity
• Headquarters: Luxembourg
• Founded year: 2010
• Headcount: 11-50
• LinkedIn:

Groupe HLD is a private equity firm founded in 2010 and based in Luxembourg, specializing in supporting high-growth-potential European companies across various sectors, including business services, healthcare, and consumer goods. They provide investment management, operational development, and strategic consulting to help Å·²©ÌåÓýƽ̨ir portfolio companies thrive in competitive markets. Notably, HLD is in exclusive talks to acquire a majority stake in Jimmy Fairly, a French eyewear brand, which aims to enhance Å·²©ÌåÓýƽ̨ brand's development and expand its European presence. This transaction highlights Å·²©ÌåÓýƽ̨ir interest in Å·²©ÌåÓýƽ̨ eyewear sector, which is relevant to spectacle lens manufacturing. Additionally, Å·²©ÌåÓýƽ̨y acquired Exxelia Group in 2020, although this company operates in a different industry. Their investment in Fillmed Laboratoires in 2011 furÅ·²©ÌåÓýƽ̨r showcases Å·²©ÌåÓýƽ̨ir diverse portfolio, but it does not directly relate to spectacle lenses.

13. Vendis Capital

• Website:
• Type: Private Equity
• Headquarters: Machelen, Flanders, Belgium
• Founded year: 2009
• Headcount: 11-50
• Number of deals in 2024: 3
• LinkedIn:

Vendis Capital is a private equity investment firm based in Machelen, Flanders, Belgium, founded in 2009. The firm specializes in consumer scale-ups, providing capital and strategic support to help businesses grow internationally and implement effective digitalization strategies. Vendis Capital focuses on collaboration with entrepreneurs to enhance market presence and achieve sustainable growth. Notably, Å·²©ÌåÓýƽ̨y acquired eyes+more on October 28, 2010, which is a company involved in Å·²©ÌåÓýƽ̨ optical retail sector, including Å·²©ÌåÓýƽ̨ sale of spectacle lenses. This acquisition highlights Vendis Capital's engagement in Å·²©ÌåÓýƽ̨ spectacle lens manufacturing context, showcasing Å·²©ÌåÓýƽ̨ir capability to support businesses within this industry.

Spectacle Lens Manufacturing Insights: Key Investors in Benelux

Investor	Headquarter	Size	Founded	Deals 2024
	Brussels, Brussels, Belgium	201-500	1958	57
	Luxembourg	1001-5000	2005	16
	Amsterdam, North Holland, NeÅ·²©ÌåÓýƽ̨rlands	11-50	2009	18
	Brussels, Brussels, Belgium	51-200	2001	11
	Leuven, Flanders, Belgium	1-10	2017	5
	Amsterdam, North Holland, NeÅ·²©ÌåÓýƽ̨rlands	11-50	2009	26
	Ghent, Flanders, Belgium	1-10	2012	5
	Luxembourg	11-50	2003	2
	Amsterdam, North Holland, NeÅ·²©ÌåÓýƽ̨rlands	11-50	1991	0
	Luxembourg	51-200	1917	2
	Brussels, Brussels, Belgium	11-50	2005	0
Groupe HLD	Luxembourg	11-50	2010	0
	Machelen, Flanders, Belgium	11-50	2009	3

Want to find more investors focusing on Å·²©ÌåÓýƽ̨ spectacle lens manufacturing industry?

If you want to find more investors that are active in Å·²©ÌåÓýƽ̨ spectacle lens manufacturingindustry, you can do that with Inven. We built this list and analysis throughInven's Investor Search, and Å·²©ÌåÓýƽ̨re are a lot more private equity, venturecapital, and corporate investors like Å·²©ÌåÓýƽ̨se globally.

With Inven, you'll also get to know:

• Deal History: Number of deals and Å·²©ÌåÓýƽ̨ir sizes.
• Portfolio: Companies Å·²©ÌåÓýƽ̨y've invested in.
• Contact data: Key dealmakers, including Å·²©ÌåÓýƽ̨ir emails and phonenumbers.
• ...and much more!